Cargando…

A Macrophage Differentiation-Mediated Gene: DDX20 as a Molecular Biomarker Encompassing the Tumor Microenvironment, Disease Staging, and Prognoses in Hepatocellular Carcinoma

BACKGROUND: DDX20 involves the mechanism of cell proliferate, mitogenic Ets transcriptional suppressor (METS), which can arrest the cell cycle of macrophages. However, little is known about DDX20 expression, clinical values, and the relationship with tumor microenvironment in HCC. METHODS: We mined...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Yi, Yang, Ming, Pang, Huasheng, Qiu, Yiwen, Sun, Ting, Wang, Tao, Shen, Shu, Wang, Wentao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556188/ https://www.ncbi.nlm.nih.gov/pubmed/36246406 http://dx.doi.org/10.1155/2022/9971776

Ejemplares similares

An Integrated Analysis of the Identified PRPF19 as an Onco-immunological Biomarker Encompassing the Tumor Microenvironment, Disease Progression, and Prognoses in Hepatocellular Carcinoma
por: Yang, Ming, et al.
Publicado: (2022)

MXD3 as an onco-immunological biomarker encompassing the tumor microenvironment, disease staging, prognoses, and therapeutic responses in multiple cancer types
por: Wu, Szu-Yuan, et al.
Publicado: (2021)

KIF11 As a Potential Pan-Cancer Immunological Biomarker Encompassing the Disease Staging, Prognoses, Tumor Microenvironment, and Therapeutic Responses
por: Guo, Xiuhong, et al.
Publicado: (2022)

A combined risk model for the multi-encompassing identification of heterogeneities of prognoses, biological pathway variations and immune states for sepsis patients
por: Yin, Zong-xiu, et al.
Publicado: (2022)

The role of TGR5 as an onco-immunological biomarker in tumor staging and prognosis by encompassing the tumor microenvironment
por: Guan, Zhiyuan, et al.
Publicado: (2022)

Immune Gene Signatures and Immunotypes in Immune Microenvironment Are Associated With Glioma Prognose
por: Wang, Xiang-Xu, et al.
Publicado: (2022)

Comprehensive Molecular Analyses of a Macrophage-Related Gene Signature With Regard to Prognosis, Immune Features, and Biomarkers for Immunotherapy in Hepatocellular Carcinoma Based on WGCNA and the LASSO Algorithm
por: Wang, Tao, et al.
Publicado: (2022)

DDX20: A Multifunctional Complex Protein
por: He, Lu, et al.
Publicado: (2023)

CCNA2 as an Immunological Biomarker Encompassing Tumor Microenvironment and Therapeutic Response in Multiple Cancer Types
por: Jiang, Aimin, et al.
Publicado: (2022)

Poor Prognoses of Young Hepatocellular Carcinoma Patients with Microvascular Invasion: A Propensity Score Matching Cohort Study
por: Li, Lian, et al.
Publicado: (2020)

Twist Expression in Circulating Hepatocellular Carcinoma Cells Predicts Metastasis and Prognoses
por: Yin, Liang-Chun, et al.
Publicado: (2018)

Identification of CD73 as a Novel Biomarker Encompassing the Tumor Microenvironment, Prognosis, and Therapeutic Responses in Various Cancers
por: Tang, Kun, et al.
Publicado: (2022)

Airway Macrophages Encompass Transcriptionally and Functionally Distinct Subsets Altered by Smoking
por: Liégeois, Maude, et al.
Publicado: (2022)

Immune cell atlas of cholangiocarcinomas reveals distinct tumor microenvironments and associated prognoses
por: Xia, Tao, et al.
Publicado: (2022)

DDX3 modulates the tumor microenvironment via its role in endoplasmic reticulum-associated translation
por: Chen, Hung-Hsi, et al.
Publicado: (2021)

Efficacy of Postoperative Adjuvant Transcatheter Arterial Chemoembolization in Hepatocellular Carcinoma Patients With Microscopic Portal Vein Invasion
por: Qiu, Yiwen, et al.
Publicado: (2022)

SOCS3 Acts as an Onco-immunological Biomarker With Value in Assessing the Tumor Microenvironment, Pathological Staging, Histological Subtypes, Therapeutic Effect, and Prognoses of Several Types of Cancer
por: Dai, Lirui, et al.
Publicado: (2022)

Typing of biliary tumor thrombus influences the prognoses of patients with hepatocellular carcinoma
por: Sun, Juxian, et al.
Publicado: (2021)

Novel hypoxia-related gene signature for predicting prognoses that correlate with the tumor immune microenvironment in NSCLC
por: Li, Zhaojin, et al.
Publicado: (2023)

Development and Validation of Artificial Neural Networks for Survival Prediction Model for Patients with Spontaneous Hepatocellular Carcinoma Rupture After Transcatheter Arterial Embolization
por: Qiu, Yiwen, et al.
Publicado: (2021)

Encompassing the globe : Portugal and the world in the 16th & 17th centuries /
Publicado: (2007)

Hepatocellular Carcinoma with Portal Vein Tumor Thrombus versus Hepatocellular Carcinoma with Biliary Tumor Thrombus: Better or Worse Prognoses? [Letter]
por: Feng, Jin-Kai, et al.
Publicado: (2021)

Relationship between Radiological Stages and Prognoses of Pneumocystis Pneumonia in Non-AIDS Immunocompromised Patients
por: Mu, Xiang-Dong, et al.
Publicado: (2016)

The Clinical Value of Long Noncoding RNA DDX11-AS1 as a Biomarker for the Diagnosis and Prognosis of Hepatocellular Carcinoma
por: Luo, Xiaojun, et al.
Publicado: (2022)

Novel postoperative nomograms for predicting individual prognoses of hepatitis B-related hepatocellular carcinoma with cirrhosis
por: Xu, Liangliang, et al.
Publicado: (2022)

Schlechte Prognose bei Schlaganfall
por: Diener, Hans-Christoph
Publicado: (2020)

Hohes Risiko, schlechte Prognose
por: Diener, Hans-Christoph
Publicado: (2021)

Schlechtere Prognose nach Schlaganfall
por: Diener, Hans-Christoph
Publicado: (2022)

DDX1 is a prognostic biomarker and correlates with immune infiltrations in hepatocellular carcinoma
por: Yuan, Mengping, et al.
Publicado: (2022)

A preliminary study of associating liver partition and portal vein ligation for staged hepatectomy in a rat model of liver cirrhosis
por: Yang, Xianwei, et al.
Publicado: (2019)

DDX11-AS1 as potential therapy targets for human hepatocellular carcinoma
por: Shi, Min, et al.
Publicado: (2017)

Basement membrane-related regulators for prediction of prognoses and responses to diverse therapies in hepatocellular carcinoma
por: Ding, Ruili, et al.
Publicado: (2023)

Systemic inflammatory response predicts poor prognoses in Barcelona Clinic Liver Cancer stage B/C hepatocellular carcinoma with transarterial chemoembolization: a prospective study
por: Huang, Zhiliang, et al.
Publicado: (2019)

A Nomogram Based on Preoperative Lipiodol Deposition after Sequential Retreatment with Transarterial Chemoembolization to Predict Prognoses for Intermediate-Stage Hepatocellular Carcinoma
por: Niu, Xiang-Ke, et al.
Publicado: (2022)

Proteomics-based identification of TMED9 is linked to vascular invasion and poor prognoses in patients with hepatocellular carcinoma
por: Yang, Yi-Chieh, et al.
Publicado: (2021)

Hepatocellular Carcinoma with Portal Vein Tumor Thrombus versus Hepatocellular Carcinoma with Biliary Tumor Thrombus: Better or Worse Prognoses? [Response to Letter]
por: Yang, Xin, et al.
Publicado: (2021)

HBx Mediated Increase of DDX17 Contributes to HBV-Related Hepatocellular Carcinoma Tumorigenesis
por: Dong, Mei-Ling, et al.
Publicado: (2022)

Learning Curve of Ex Vivo Liver Resection and Autotransplantation in Treating End-Stage Hepatic Alveolar Echinococcosis: A RA-CUSUM Analysis
por: Qiu, Yiwen, et al.
Publicado: (2021)

Early macrophage response to obesity encompasses Interferon Regulatory Factor 5 regulated mitochondrial architecture remodelling
por: Orliaguet, L., et al.
Publicado: (2022)

Clinical characteristics and prognoses of pulmonary mucormycosis in four children
por: Guo, Siyuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4la0qlgog3hbqpifufpn00rb09